조영제 유발 신독성

키워드

참고문헌 (81)

1. McCullough PA, "Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality", Am J Med, 103, pp.368~375 (1997)
2. McCullough PA, "Epidemiology and prognostic implications of contrast-induced nephropathy", Am J Cardiol, 98, pp.5K~13K (2006)
3. Jorgensen AL, "Contrast-induced nephropathy: pathophysiology and preventive strategies", Crit Care Nurse, 33, pp.37~46 (2013)
4. Feldkamp T, "Contrast media induced nephropathy:definition, incidence, outcome, pathophysiology, risk factors and prevention", Minerva Med, 99, pp.177~196 (2008)
5. Murphy SW, "Contrast nephropathy", J Am Soc Nephrol, 11, pp.177~182 (2000)
6. Mohammed NM, "Contrast-induced Nephropathy", Heart Views, 14, pp.106~116 (2013)
7. Solomon R, "Contrast-medium-induced acute renal failure", Kidney Int, 53, pp.230~242 (1998)
8. Harjai KJ, "A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system", Am J Cardiol, 101, pp.812~819 (2008)
9. Goldenberg I, "Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies", CMAJ, 172, pp.1461~1471 (2005)
10. Cruz DN, "Renal replacement therapies for prevention of radiocontrast-induced nephropathy: a systematic review", Am J Med, 125, pp.66~78.e3. (2012)
11. Hou SH, "Hospital-acquired renal insufficiency: a prospective study", Am J Med, 74, pp.243~248 (1983)
12. Mizushima N, "Autophagy fights disease through cellular self-digestion", Nature, 451, pp.1069~1075 (2008)
13. Morcos SK, "Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR)", Eur Radiol, 9, pp.1602~1613 (1999)
14. Rudnick MR, "Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study", Kidney Int, 47, pp.254~261 (1995)
15. Manske CL, "Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography", Am J Med, 89, pp.615~620 (1990)
16. Kooiman J, "Meta-analysis: serum creatinine changes following contrast enhanced CT imaging", Eur J Radiol, 81, pp.2554~2561 (2012)
17. Karlsberg RP, "Contrast-induced acute kidney injury (CI-AKI) following intra-arterial administration of iodinated contrast media", J Nephrol, 23, pp.658~666 (2010)
18. Persson PB, "Pathophysiology of contrast medium-induced nephropathy", Kidney Int, 68, pp.14~22 (2005)
19. Heyman SN, "Pathophysiology of radiocontrast nephropathy: a role for medullary hypoxia", Invest Radiol, 34, pp.685~691 (1999)
20. Bakris GL, "Oxygen free radical involvement in urinary Tamm-Horsfall protein excretion after intrarenal injection of contrast medium", Radiology, 175, pp.57~60 (1990)
21. Romano G, "Contrast agents and renal cell apoptosis", Eur Heart J, 29, pp.2569~2576 (2008)
22. Hizoh I, "Radiocontrast-induced renal tubular cell apoptosis: hypertonic versus oxidative stress", Invest Radiol, 37, pp.428~434 (2002)
23. Mehran R, "Contrast-induced nephropathy: definition, epidemiology, and patients at risk", Kidney Int Suppl, 100, pp.S11~S15 (2006)
24. Bartholomew BA, "Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification", Am J Cardiol, 93, pp.1515~1519 (2004)
25. Mehran R, "A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation", J Am Coll Cardiol, 44, pp.1393~1399 (2004)
26. Marenzi G, "Can contrast-induced nephropathy after percutaneous coronary intervention be accurately predicted with a risk score?", Nat Clin Pract Cardiovasc Med, 2, pp.80~81 (2005)
27. Haase M, "The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies", J Am Coll Cardiol, 57, pp.1752~1761 (2011)
28. Bachorzewska-Gajewska H, "NGAL (neutrophil gelatinase-associated lipocalin) and L-FABP after percutaneous coronary interventions due to unstable angina in patients with normal serum creatinine", Adv Med Sci, 54, pp.221~224 (2009)
29. Mishra J, "Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery", Lancet, 365, pp.1231~1238 (2005)
30. Bachorzewska-Gajewska H, "Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions", Am J Nephrol, 26, pp.287~292 (2006)
31. Soto K, "Cystatin C as a marker of acute kidney injury in the emergency department", Clin J Am Soc Nephrol, 5, pp.1745~1754 (2010)
32. Zappitelli M, "Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study", Crit Care, 11, pp.R84~ (2007)
33. Ling W, "Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography", Nephron Clin Pract, 108, pp.c176~c181 (2008)
34. Nakamura T, "Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy", Am J Kidney Dis, 47, pp.439~444 (2006)
35. Slocum JL, "Marking renal injury:can we move beyond serum creatinine?", Transl Res, 159, pp.277~289 (2012)
36. Nogare AL, "Noninvasive analyses of kidney injury molecule-1 messenger RNA in kidney transplant recipients with graft dysfunction", Transplant Proc, 44, pp.2297~2299 (2012)
37. Brown JR, "Does safe dosing of iodinated contrast prevent contrast-induced acute kidney injury?", Circ Cardiovasc Interv, 3, pp.346~350 (2010)
38. Nyman U, "Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention", Acta Radiol, 49, pp.658~667 (2008)
39. Vlietstra RE, "Contrast nephropathy after coronary angioplasty in chronic renal insufficiency", Am Heart J, 132, pp.1049~1050 (1996)
40. Barrett BJ, "Metaanalysis of the relative nephrotoxicity of high-and low-osmolality iodinated contrast media", Radiology, 188, pp.171~178 (1993)
41. Laskey W, "Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures", Am Heart J, 158, pp.822~828.e3. (2009)
42. Kuhn MJ, "The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low-or isoosmolar contrast agent exposure", AJR Am J Roentgenol, 191, pp.151~157 (2008)
43. Feldkamp T, "Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients", Clin Nephrol, 66, pp.322~330 (2006)
44. Heinrich MC, "Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials", Radiology, 250, pp.68~86 (2009)
45. Alexopoulos E, "Contrastinduced acute kidney injury in patients with renal dysfunction undergoing a coronary procedure and receiving nonionic low-osmolar versus iso-osmolar contrast media", Am J Med Sci, 339, pp.25~30 (2010)
46. Nie B, "A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention", Catheter Cardiovasc Interv, 72, pp.958~965 (2008)
47. Jo SH, "Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial", J Am Coll Cardiol, 48, pp.924~930 (2006)
48. Boyden TF, "Does gadolinium-based angiography protect against contrast-induced nephropathy?: a systematic review of the literature", Catheter Cardiovasc Interv, 71, pp.687~693 (2008)
49. Kane GC, "Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes", Nephrol Dial Transplant, 23, pp.1233~1240 (2008)
50. Briguori C, "Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures", Catheter Cardiovasc Interv, 67, pp.175~180 (2006)
51. Ergün I, "The safety of gadolinium in patients with stage 3 and 4 renal failure", Nephrol Dial Transplant, 21, pp.697~700 (2006)
52. Erley CM, "Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients", Nephrol Dial Transplant, 19, pp.2526~2531 (2004)
53. Mueller C, "Prevention of contrast-induced nephropathy with volume supplementation", Kidney Int Suppl, 100, pp.S16~S19 (2006)
54. Weisbord SD, "Prevention of contrast-induced nephropathy with volume expansion", Clin J Am Soc Nephrol, 3, pp.273~280 (2008)
55. Briguori C, "Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL):a randomized comparison of 3 preventive strategies", Circulation, 115, pp.1211~1217 (2007)
56. Solomon R, "Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents", N Engl J Med, 331, pp.1416~1420 (1994)
57. Mueller C, "Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty", Arch Intern Med, 162, pp.329~336 (2002)
58. Bader BD, "What is the best hydration regimen to prevent contrast media-induced nephrotoxicity?", Clin Nephrol, 62, pp.1~7 (2004)
59. Stacul F, "Strategies to reduce the risk of contrast-induced nephropathy", Am J Cardiol, 98, pp.59K~77K (2006)
60. Taylor AJ, "PREPARED:Preparation for angiography in renal dysfunction: a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction", Chest, 114, pp.1570~1574 (1998)
61. Trivedi HS, "A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity", Nephron Clin Pract, 93, pp.29~34 (2003)
62. Jo SH, "Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial-a randomized controlled study", Am Heart J, 155, pp.499~e1-e8 (2008)
63. Caulfield JL, "Bicarbonate inhibits N-nitrosation in oxygenated nitric oxide solutions", J Biol Chem, 271, pp.25859~25863 (1996)
64. Merten GJ, "Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial", JAMA, 291, pp.2328~2334 (2004)
65. Joannidis M, "Prevention of contrast media-induced nephropathy by isotonic sodium bicarbonate:a meta-analysis", Wien Klin Wochenschr, 120, pp.742~748 (2008)
66. Jo SH, "N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial", Am Heart J, 157, pp.576~583 (2009)
67. Marenzi G, "N-acetylcysteine and contrast-induced nephropathy in primary angioplasty", N Engl J Med, 354, pp.2773~2782 (2006)
68. Vaitkus PT, "N-acetylcysteine in the prevention of contrast-induced nephropathy: publication bias perpetuated by meta-analyses", Am Heart J, 153, pp.275~280 (2007)
69. Spargias K, "Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention", Circulation, 110, pp.2837~2842 (2004)
70. Huber W, "Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study", Radiology, 223, pp.772~779 (2002)
71. Neumayer HH, "Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: a prospective randomised clinical trial", Nephrol Dial Transplant, 4, pp.1030~1036 (1989)
72. Kapoor A, "Use of dopamine in prevention of contrast induced acute renal failure-a randomised study", Int J Cardiol, 53, pp.233~236 (1996)
73. Stone GW, "Fenoldopam mesylate for the prevention of contrast-induced nephropathy:a randomized controlled trial", JAMA, 290, pp.2284~2291 (2003)
74. Koch JA, "Prostaglandin E1: a new agent for the prevention of renal dysfunction in high risk patients caused by radiocontrast media? PGE1Study Group", Nephrol Dial Transplant, 15, pp.43~49 (2000)
75. Khanal S, "Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions", Am J Med, 118, pp.843~849 (2005)
76. Erol T, "Efficacy of allopurinol pretreatment for prevention of contrast-induced nephropathy:a randomized controlled trial", Int J Cardiol, 167, pp.1396~1399 (2013)
77. Cruz DN, "The role of extracorporeal blood purification therapies in the prevention of radiocontrast-induced nephropathy", Int J Artif Organs, 31, pp.515~524 (2008)
78. Lee PT, "Renal protection for coronary angiography in advanced renal failure patients by prophylactic hemodialysis. A randomized controlled trial", J Am Coll Cardiol, 50, pp.1015~1020 (2007)
79. Marenzi G, "Continuous veno-venous hemofiltration for the treatment of contrast-induced acute renal failure after percutaneous coronary interventions", Catheter Cardiovasc Interv, 58, pp.59~64 (2003)
80. Guastoni C, "Continuous venovenous hemofiltration after coronary procedures for the prevention of contrast-induced acute kidney injury in patients with severe chronic renal failure", Am J Cardiol, 113, pp.588~592 (2014)
81. Choi MJ, "The prevention of contrast-induced nephropathy by simultaneous hemofiltration during coronary angiographic procedures: a comparison with periprocedural hemofiltration", Int J Cardiol, 176, pp.941~945 (2014)

관련 논문AI추천